Telangana, India’s youngest state, has rapidly emerged as one of Asia’s foremost life sciences hubs, housing more than 2,000 life sciences companies with a combined valuation exceeding USD 100 billion. The state accounts for one-third of the global vaccine output, earning Hyderabad the title of the “Vaccine Capital of the World”, and contributes nearly 40% of India’s total pharmaceutical production. Telangana is now ranked 7th among global life sciences hubs (CBRE Global Life Sciences Atlas 2025), hosts 8 of the world’s top 10 pharmaceutical companies, and operates with an unmatched scale of 269+ USFDA-approved facilities, the highest concentration anywhere in the world.

Telangana has a rich mix of leading global life sciences companies, including Novartis, Johnson & Johnson, Eli Lilly, Bristol Myers Squibb (BMS), Sanofi, Amgen, Roche, Medtronic, Bayer, UnitedHealth Group, Olympus, GE Healthcare, Thermo Fisher Scientific, Ferring Pharmaceuticals, Sandoz, Parexel, IQVIA, Zoetis, Evernorth, Providence, MSD, B. Braun, DuPont, Chemo, AMRI, Miltenyi Biotec, Eurofins, Ashland, Adama, Curia Global, Jamp Pharma, USP, Viatris, Slayback Pharma, TCI, Croda, The Jackson Laboratory, Daicel, DFE Pharma, Envigo, Meiji (Lotus Company), ALS Global, Neuland, among others. The state is also home to several leading Indian multinationals such as Dr. Reddy’s Laboratories, Aurobindo Pharma, Hetero Drugs, MSN Labs, Bharat Biotech, Biological E., Indian Immunologicals, Aurigene, Pi Health Sciences, Aragen Life Sciences, Sai Life Sciences, Syngene, Laurus Labs, Gland Pharma, Divi’s Laboratories, and Granules India, among others. Telangana also has a strong and expanding MedTech ecosystem, including SMT (Sahajanand Medical Technologies), Huwel, Sensa Core, and Akriti, along with a rapidly growing base of emerging biotech and MedTech innovators.

The Government of Telangana continues to prioritise life sciences as a strategic sector. World-class infrastructure, progressive policies, a cluster-based development model, and a highly skilled scientific talent pool have created a unique and globally competitive identity for Hyderabad. These strengths have consistently attracted major global and domestic investments, with the sector drawing nearly 185 greenfield projects worth USD 7 billion in the last two years.